J Crofton. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Drug CombinationsDrug Resistance, MicrobialEthambutol/pharmacologyEthambutol/therapeutic useHumansRifampin/pharmacologyRifampin/therapeutic useTuberculosis/drug therapyUnited KingdomUnited States
Substances: See more » Drug CombinationsEthambutolRifampin
Year: 1971 PMID: 5159677 PMCID: PMC2467357 DOI: 10.1136/pgmj.47.553.748
Source DB: PubMed Journal: Postgrad Med J ISSN: 0032-5473 Impact factor: 2.401